Health
Metformin use reduces risk of death for patients with Covid-19, diabetes – Hindustan Times
Use of the diabetes drug metformin, before a diagnosis of Covid-19 is associated with a threefold decrease in mortality in Covid-19 patients with Type 2 diabetes,…
Use of the diabetes drug metformin — before a diagnosis of Covid-19 is associated with a threefold decrease in mortality in Covid-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham.
Diabetes is a significant comorbidity for Covid-19.
“This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive…
-
Noosa News11 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News19 hours agoCountdown on for Noosa Eat & Drink Festival 2025
-
Noosa News16 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News18 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common